CHI3L1 and obstructive sleep apnea syndrome: The study expressed the need for more consistent and robust investigations to better understand the significance of serum concentrations of YKL-40 in OSA patients and to evaluate whether monitoring their concentrations can reflect disease phases and support successful therapeutic decisions.